NCT03745534 is a clinical trial of eABR in Vestibular Schwannoma, sponsored by Christoph Arnoldner.

Who is sponsoring NCT03745534?

NCT03745534 is sponsored by Christoph Arnoldner.

What drugs are being tested in NCT03745534?

Interventions in NCT03745534: eABR.

What condition does NCT03745534 study?

NCT03745534 studies Vestibular Schwannoma, Hearing Loss.

Is NCT03745534 still recruiting?

NCT03745534 is currently recruiting now. Last updated 25 November 2024.

Last reviewed 2024-11-25 · How we verify

NCT03745534

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study

Recruiting now Last updated 25 November 2024

What this trial tests

trial testing eABR in Vestibular Schwannoma in 8 participants. Currently enrolling.

Timeline

1 August 2018

Primary endpoint
31 July 2026

30 October 2026

Quick facts

Lead sponsor	Christoph Arnoldner
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	8
Start date	1 August 2018
Primary completion	31 July 2026
Estimated completion	30 October 2026
Sites	1 location across Austria

Drugs / interventions tested

eABR

Conditions studied

Vestibular Schwannoma — all drugs for Vestibular Schwannoma →
Hearing Loss — all drugs for Hearing Loss →

Sponsor

Christoph Arnoldner

Who can join

18 and older, any sex, with Vestibular Schwannoma or Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing cochlear implantation after radio surgery for vestibular schwannoma will be included in the study. Patients will undergo preoperative and intraoperative eABR measurement. Correlations to postoperative hearing results will be drawn.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vestibular Schwannoma

Currently open trials in the same condition.

NCT07364955 — Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma · NA · recruiting
NCT07130851 — Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma · NA · active not recruiting
NCT06572475 — USPIO Enhanced MR Imaging in CNS Tumours (UMIC) · NA · recruiting
NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting
NCT05641441 — Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma · recruiting

Other Christoph Arnoldner trials

Trials by the same sponsor.

NCT03248856 — Triamcinolone Levels in Cochlear Perilymph · Phase 1 · completed
NCT03745560 — Intraoperative EABR for Decision Making · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03745534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Christoph Arnoldner
Last refreshed: 25 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing